P3 SAR exploration of biphenyl carbamate based Legumain inhibitors.

Bioorg Med Chem Lett

CCRCB Drug Discovery Group, Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Rd., Belfast BT9 7BL, UK. Electronic address:

Published: June 2014

This Letter describes the further development and SAR exploration of a novel series of Legumain inhibitors. Based upon a previously identified Legumain inhibitor from our group, we explored the SAR of the carbamate phenyl ring system to probe the P3 pocket of the enzyme. This led to the identification of a sub-nanomolar inhibitor of Legumain.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2014.04.002DOI Listing

Publication Analysis

Top Keywords

sar exploration
8
legumain inhibitors
8
exploration biphenyl
4
biphenyl carbamate
4
carbamate based
4
legumain
4
based legumain
4
inhibitors letter
4
letter describes
4
describes development
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!